Luís Morano

1.5k total citations
65 papers, 543 citations indexed

About

Luís Morano is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Luís Morano has authored 65 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 37 papers in Hepatology and 10 papers in Infectious Diseases. Recurrent topics in Luís Morano's work include Hepatitis C virus research (34 papers), Liver Disease Diagnosis and Treatment (24 papers) and Hepatitis B Virus Studies (20 papers). Luís Morano is often cited by papers focused on Hepatitis C virus research (34 papers), Liver Disease Diagnosis and Treatment (24 papers) and Hepatitis B Virus Studies (20 papers). Luís Morano collaborates with scholars based in Spain, United States and Italy. Luís Morano's co-authors include Juan A. Pineda, Rafael Granados, Juan Macı́as, Francisco Téllez, Antonio Rivero‐Juárez, José A. Oteo, Féderico García, Dolores Merino, Rosario Palacios and Marı́a Buti and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Luís Morano

61 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luís Morano Spain 13 328 324 112 30 26 65 543
Katia Alves United States 12 437 1.3× 399 1.2× 353 3.2× 26 0.9× 25 1.0× 21 720
M.K. Mohamed Egypt 13 533 1.6× 581 1.8× 43 0.4× 44 1.5× 18 0.7× 21 835
Shubham Jain India 10 254 0.8× 192 0.6× 52 0.5× 21 0.7× 9 0.3× 48 471
Wenli Fan Canada 16 344 1.0× 174 0.5× 127 1.1× 25 0.8× 9 0.3× 30 715
Van Thi Thuy Nguyen Vietnam 11 433 1.3× 317 1.0× 154 1.4× 64 2.1× 6 0.2× 29 603
Ifeanyichukwu U. Ezebialu Nigeria 12 253 0.8× 102 0.3× 30 0.3× 18 0.6× 2 0.1× 37 549
Syed Ejaz Alam Pakistan 13 342 1.0× 299 0.9× 51 0.5× 10 0.3× 2 0.1× 40 519
Su H China 12 280 0.9× 215 0.7× 43 0.4× 130 4.3× 8 0.3× 40 583
Rodrigo de Carvalho Santana Brazil 12 139 0.4× 56 0.2× 99 0.9× 47 1.6× 6 0.2× 39 440
Andrew Fowell United Kingdom 12 259 0.8× 290 0.9× 25 0.2× 39 1.3× 6 0.2× 32 592

Countries citing papers authored by Luís Morano

Since Specialization
Citations

This map shows the geographic impact of Luís Morano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luís Morano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luís Morano more than expected).

Fields of papers citing papers by Luís Morano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luís Morano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luís Morano. The network helps show where Luís Morano may publish in the future.

Co-authorship network of co-authors of Luís Morano

This figure shows the co-authorship network connecting the top 25 collaborators of Luís Morano. A scholar is included among the top collaborators of Luís Morano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luís Morano. Luís Morano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morano, Luís, Jordi Navarro, Rafael Granados, et al.. (2024). Rate of hepatitis C reinfection after successful direct-acting antivirals treatment among people who inject drugs in Spain: the LIVERate study. BMC Public Health. 24(1). 3167–3167. 1 indexed citations
2.
Collazos, Julio, Luís Morano, Manuel Rodríguez, et al.. (2024). No gender differences in the 24-month course of non-invasive liver fibrosis markers after DAA therapy in HCV-mono and HCV/HIV-coinfected patients. Scientific Reports. 14(1). 7534–7534. 2 indexed citations
3.
Collazos, Julio, Luís Morano, Manuel Rodríguez, et al.. (2022). 24-month decline of non-invasive liver fibrosis markers in HCV-mono and HCV/HIV coinfection after direct-acting antiviral therapy. Scientific Reports. 12(1). 3828–3828. 3 indexed citations
4.
Corma‐Gómez, Anaïs, Juan Macı́as, Antonio Rivero, et al.. (2021). A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure. Diagnostics. 11(8). 1501–1501. 1 indexed citations
5.
González‐Serna, Alejandro, Anaïs Corma‐Gómez, Francisco Téllez, et al.. (2021). Liver stiffness change with HCV cure in HIV-infected patients on non-nucleoside analogues. Journal of Antimicrobial Chemotherapy. 76(9). 2375–2379. 3 indexed citations
6.
Macı́as, Juan, Luís Morano, Francisco Téllez, et al.. (2019). Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy. Journal of Hepatology. 71(1). 45–51. 44 indexed citations
8.
Macı́as, Juan, Francisco Téllez, Antonio Rivero‐Juárez, et al.. (2018). Early emergence of opportunistic infections after starting direct‐acting antiviral drugs in HIV/HCV‐coinfected patients. Journal of Viral Hepatitis. 26(1). 48–54. 4 indexed citations
9.
Real, Luís Miguel, Juan Macı́as, Ana Belén Pérez, et al.. (2018). Baseline resistance-guided therapy does not enhance the response to interferon-free treatment of HCV infection in real life. Scientific Reports. 8(1). 14905–14905. 3 indexed citations
10.
Macı́as, Juan, Rafael Granados, Francisco Téllez, et al.. (2018). Similar recovery of liver function after response to all‐oral HCV therapy in patients with cirrhosis with and without HIV coinfection. Journal of Viral Hepatitis. 26(1). 16–24. 10 indexed citations
11.
Pineda, Juan A., Féderico García, Miguel García Deltoro, et al.. (2018). Executive summary: Consensus document of GEHEP of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), along with SOCIDROGALCOHOL, SEPD and SOMAPA on hepatitis C virus infection management in drug users. Enfermedades Infecciosas y Microbiología Clínica. 38(3). 127–131. 9 indexed citations
12.
Morano, Luís, et al.. (2015). Pharmaceutical intervention for medication reconciliation at admission in a department of orthopaedic surgery and traumatology. Analysis of avoided costs. 17(2). 6.
13.
Lin, Hong, MS Islam, Luís Morano, et al.. (2013). GENETIC VARIATION OF XYLELLA FASTIDIOSA ASSOCIATED WITH GRAPEVINES IN TWO MAJOR VITICULTURAL REGIONS IN THE UNITED STATES: CALIFORNIA AND TEXAS. Journal of Plant Pathology. 95(2). 329–337. 3 indexed citations
14.
Morano, Luís, et al.. (2006). Patología orgánica en adicciones: Otras infecciones asociadas al consumo de drogas. Adicciones. 18(1). 137–159. 1 indexed citations
15.
Oteo, José A., et al.. (2006). Endocarditis por Bartonella spp. Aportación de tres nuevos casos y revisión de la literatura nacional. Enfermedades Infecciosas y Microbiología Clínica. 24(5). 297–301. 12 indexed citations
16.
Morano, Luís, et al.. (2003). Trombosis venosa masiva con invasión cardiaca como primera manifestación de un hepatocarcinoma. Anales de Medicina Interna. 20(10). 537–9. 3 indexed citations
18.
Morano, Luís, et al.. (2002). Bacteriemia nosocomial en el paciente adulto. Estudio de costes asociados. Revista Clínica Española. 202(9). 476–484. 5 indexed citations
19.
Morano, Luís, et al.. (2001). Paroniquia en pacientes infectados por el VIH tratados con indinavir. Revista Clínica Española. 201(8). 455–458. 1 indexed citations
20.
Morano, Luís, et al.. (1997). [Fulminant liver failure with a fatal outcome due to flutamide].. PubMed. 108(6). 237–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026